Melasma - ໝາກ ໂມ
☆ ໃນປີ 2022 Stiftung Warentest ຜົນໄດ້ຮັບຈາກເຢຍລະມັນ, ຄວາມພໍໃຈຂອງຜູ້ບໍລິໂພກກັບ ModelDerm ແມ່ນຕໍ່າກວ່າການປຶກສາຫາລືທາງດ້ານການປິ່ນປົວທາງໂທລະສັບເລັກນ້ອຍເທົ່ານັ້ນ.
ມັນເປັນສະພາບທົ່ວໄປທີ່ສັງເກດເຫັນໃນແມ່ຍິງອາຊີໃນໄວ 40s ຂອງເຂົາເຈົ້າ. ບາດແຜເປັນວົງໃນຮູບແມ່ນໃກ້ຊິດກັບ lentigo ຫຼາຍກວ່າ melasma.
References
Tranexamic acid is a novel treatment option for melasma; however, there is no consensus on its use. This systematic review searched major databases for relevant publications to March 2016. Eleven studies with 667 participants were included. Pooled data from tranexamic acid-only observational studies with pre- and post-treatment Melasma Area and Severity Index (MASI) showed a decrease of 1.60 in MASI after treat?ment with tranexamic acid. The addition of tranexamic acid to routine treatment modalities resulted in a further decrease in MASI of 0.94. These results support the efficacy and safety of tranexamic acid, either alone or as an adjuvant to routine treatment modalities for melasma.
ບໍ່ດົນມານີ້, low-fluence Q-switched Nd:YAG (LFQSNY) laser ໄດ້ກາຍເປັນທີ່ນິຍົມໃນການປິ່ນປົວ melasma, ໂດຍສະເພາະໃນອາຊີ. ການສະຫຼຸບການສຶກສາທີ່ຫຼາກຫຼາຍແມ່ນມີຄວາມທ້າທາຍ, ແຕ່ LFQSNY ເບິ່ງຄືວ່າໂດຍທົ່ວໄປແລ້ວປະສິດທິຜົນແລະປອດໄພສໍາລັບ melasma ເມື່ອທຽບກັບການປິ່ນປົວແບບດັ້ງເດີມ. ຢ່າງໃດກໍຕາມ, ບາງກໍລະນີຂອງ hypopigmentation mottled ໄດ້ຖືກລາຍງານວ່າເປັນຜົນຂ້າງຄຽງຂອງ LFQSNY, ອາດຈະເປັນຍ້ອນພະລັງງານ laser ສູງ. ການນໍາໃຊ້ຢ່າງຮຸກຮານຂອງ LFQSNY ຍັງສາມາດນໍາໄປສູ່ການ hyperpigmentation ຈາກການອັກເສບ, ໂດຍສະເພາະໃນຜິວຫນັງທີ່ຊ້ໍາ.
Recently, the low-fluence Q-switched Nd:YAG laser (LFQSNY) has been widely used for treating melasma, especially in Asia. It was hard to summarize the heterogenous studies, but LFQSNY appeared to be a generally effective and safe treatment for melasma considering the results of previous conventional therapies. However, mottled hypopigmentation has been occasionally reported to develop and persist as an adverse event of LFQSNY, which may be associated with the high accumulated laser energy. When used aggressively, even LFQSNY can induce hyperpigmentation via unwanted inflammation, especially in darker skin.
Recently, the low-fluence Q-switched Nd:YAG laser (LFQSNY) has been widely used for treating melasma, especially in Asia. It was hard to summarize the heterogenous studies, but LFQSNY appeared to be a generally effective and safe treatment for melasma considering the results of previous conventional therapies. However, mottled hypopigmentation has been occasionally reported to develop and persist as an adverse event of LFQSNY, which may be associated with the high accumulated laser energy. When used aggressively, even LFQSNY can induce hyperpigmentation via unwanted inflammation, especially in darker skin.
ບັນຫາເມັດສີແມ່ນມັກຈະພົບເຫັນຢູ່ໃນການດູແລຂັ້ນຕົ້ນ. ປະເພດທົ່ວໄປຂອງຄວາມຜິດປົກກະຕິຂອງ hyperpigmentation ປະກອບມີ post-inflammatory hyperpigmentation, melasma, sunspots, freckles, café au lait spots.
Pigmentation problems are often found in primary care. Common types of hyperpigmentation disorders include post-inflammatory hyperpigmentation, melasma, sunspots, freckles, café au lait spots.
Pigmentation problems are often found in primary care. Common types of hyperpigmentation disorders include post-inflammatory hyperpigmentation, melasma, sunspots, freckles, café au lait spots.
Melasma ບໍ່ສາມາດແກ້ໄຂໄດ້ດ້ວຍການປິ່ນປົວດ້ວຍເລເຊີໃນໄລຍະເວລາທີ່ແນ່ນອນ, ເພາະວ່າມັນເປັນພະຍາດທີ່ຜະລິດເມັດສີຢ່າງຕໍ່ເນື່ອງ. ກົດ Tranxenemic ຊ່ວຍປັບປຸງເພື່ອຫຼຸດຜ່ອນເມັດສີ.
○ ການປິ່ນປົວ
ໃນບາງປະເທດ (ເຊັ່ນ: ຍີ່ປຸ່ນ, ເກົາຫຼີ), ອາຊິດ tranexamic ທາງປາກແມ່ນມີຢູ່ໃນຕົວຕ້ານທານແລະມີປະສິດທິພາບ. ຄີມ melasma ທີ່ມີອາຊິດ tranexamic ແລະອາຊິດ azelaic ອາດຈະເປັນປະໂຫຍດບາງສ່ວນ.
Hydroquinone ອາດຈະຖືກນໍາໃຊ້ໃນຫົວຂໍ້ສໍາລັບການປິ່ນປົວ hyperpigmentation, ແຕ່ FDA ຢຸດເຊົາການຜະລິດຕະພັນ OTC ທີ່ມີ hydroquinone ໃນປີ 2020.
#Tranexamic acid [TRANSINO]
#Laser toning technique (low fluence QS1064 laser)
#Triluma